Curasight
BioStock: Curasight gets green light from EMA in phase II prostate cancer trial
Read the full article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se
| Datum | 2024-04-22, kl 08:45 |
| Källa | Cision |